Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.
Ferreiro-Iglesias R, Porto Silva S, Marín S, Casanova MJ, Mañosa M, González-Muñoza C, de Francisco R, Caballol B, Arias L, Piqueras M, Zabana Y, Rivero M, Calvet X, Mesonero F, Varela Trastoy P, Busta Nistal R, Gómez Perosanz R, Vega P, Gonzalez-Vivo M, Iborra M, Bermejo F, Madero L, Rodríguez-Lago I, Rodríguez Gonzalez M, Vera I, Ponferrada Díaz Á, Vela M, Torrealba Medina L, Van Domselaar M, Gomollón F, Iglesias E, Gisbert JP, Calafat M, Giordano A, Pérez-Martínez I, Ricart E, Sicilia B, Mena R, Esteve M, Rivas C, Brunet-Mas E, Fernández C, de Jorge Turrión MÁ, Velayos Jiménez B, Quiñones Calvo M, Regueiro Expósito C, Márquez-Mosquera L, Nos P, Granja A, Gutiérrez A, Cabriada JL, Hervías Cruz D, Calvo M, Pérez Pérez J, Rodríguez Díaz Y, Busquets Casal D, Menacho M, Leal C, Lucendo AJ, Royo V, Olivares S, Álvarez Herrero B, Carrillo-Palau M, Gilabert Álvarez P, Manceñido Marcos N, Martínez-Pérez TJ, Muñoz Villafranca MC, Almela P, Argüelles-Arias F, Legido J, Fuentes Coronel AM, Nieto L, Domènech E, Barreiro-de Acosta M; ENEIDA project sponsored by GETECCU. Ferreiro-Iglesias R, et al. Among authors: arguelles arias f. Aliment Pharmacol Ther. 2024 Sep;60(5):604-612. doi: 10.1111/apt.18133. Epub 2024 Jun 28. Aliment Pharmacol Ther. 2024. PMID: 38943230
Clinical utility of urinary gluten immunogenic peptides in the follow-up of patients with coeliac disease.
Garzón-Benavides M, Ruiz-Carnicer Á, Segura V, Fombuena B, García-Fernandez F, Sobrino-Rodriguez S, Gómez-Izquierdo L, Montes-Cano MA, Millan-Domínguez R, Del Carmen Rico M, González-Naranjo C, Bozada-García JM, Coronel-Rodríguez C, Espin B, Díaz J, Comino I, Argüelles-Arias F, Cebolla Á, Romero-Gómez M, Rodriguez-Herrera A, Sousa C, Pizarro-Moreno Á. Garzón-Benavides M, et al. Aliment Pharmacol Ther. 2023 May;57(9):993-1003. doi: 10.1111/apt.17417. Epub 2023 Mar 8. Aliment Pharmacol Ther. 2023. PMID: 36890679
Ustekinumab in Crohn's disease: real-world outcomes and predictors of response.
Lorenzo González L, Valdés Delgado T, Vázquez Morón JM, Castro Laria L, Leo Carnerero E, Maldonado Pérez MB, Sánchez Capilla D, Pallarés Manrique H, Sáez Díaz A, Argüelles Arias F; Grupo de Enfermedad Inflamatoria de Andalucía. Lorenzo González L, et al. Rev Esp Enferm Dig. 2022 May;114(5):272-279. doi: 10.17235/reed.2020.7352/2020. Rev Esp Enferm Dig. 2022. PMID: 33393332 Free article.
Use of Darvadstrocel (Allogenic Stem Cell Therapy) for Crohn's Fistulas in Real Clinical Practice: The National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study).
Herreros MD, Ramirez JM, Otero-Piñeiro AM, Martí-Gallostra M, Badiola I, Enríquez-Navascues JM, Millan M, Barreiro EM, De La Portilla F, Suárez Alecha J, García-Olmo D; National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn’s Fistula (the PRIME Study) Group. Herreros MD, et al. Dis Colon Rectum. 2024 Jul 1;67(7):960-967. doi: 10.1097/DCR.0000000000003216. Epub 2024 Apr 11. Dis Colon Rectum. 2024. PMID: 38603800
Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.
Giordano A, Pérez-Martínez I, Gisbert JP, Ricart E, Martín-Arranz MD, Mesonero F, De Castro Parga ML, Rivero M, Iglesias E, Fernández-Prada S, Calafat M, Arroyo Villarino MT, Ángel de Jorge Turrión M, Hernandez-Camba A, Lidón RV, Carpio D, Brunet E, Moranta FR, García LA, Cuquerella JT, Bermejo F, Madero L, Esteve M, González-Muñoza C, Martínez-Montiel P, Huguet JM, Pérez Calle JL, Rodríguez-Lago I, Ausín MS, Lorente Poyatos RH, García-Bosch O, Marín GS, Taxonera C, Ponferrada-Diaz Á, Acosta MB, Bujanda L, Serra RB, Ramos L, Vera I, Abizanda ES, Piqueras M, Gómez CS, García-Sepulcre MF, Arregui MV, Murillo NR, LLaó J, Lucendo AJ, Marín-Jiménez I, Camps-Aler B, Villafranca CM, Ceballos D, Ver Y, Fernández-Salazar LI, Alcaín G, Valldosera G, Andrés PR, Martínez-Flores C, Coronel AF, Ginard D, García L, Gómez IB, Argüelles-Arias F, Miyashiro EI, De la Piscina PR, Villalba LH, Notari PA, de Jesús Martínez-Pérez T, Fernández H, Gilabert P, Rosas CM, Nos P, Gil JL, Navas López VM, Muñoz F, Diz-Lois Palomares MT, Lucio AS, Merino O, Nicolás de Prado I, Leal C, Martín de Carpi J, Sánchez LB, Arce NM, Frago S, Mateu BB, Domènech E, Planella EG; ENEIDA project of GETECCU. Giordano A, et al. Among authors: arguelles arias f. Am J Gastroenterol. 2025 Jan 1;120(1):194-203. doi: 10.14309/ajg.0000000000003207. Epub 2024 Nov 14. Am J Gastroenterol. 2025. PMID: 39745305
Carriage of the HLA-DQA1⋆05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-TNF for inflammatory bowel disease.
Navajas Hernández P, Mouhtar El Halabi S, González Parra AC, Valdés Delgado T, Maldonado Pérez B, Castro Laria L, Charpentier C, Argüelles-Arias F. Navajas Hernández P, et al. Among authors: arguelles arias f. Therap Adv Gastroenterol. 2024 Oct 16;17:17562848241278145. doi: 10.1177/17562848241278145. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39421002 Free PMC article.
High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease.
González-Antuña J, Valdés-Delgado T, Maldonado-Pérez B, Belvis-Jiménez M, Castro-Laria L, Merino-Bohórquez V, Calleja-Hernández MÁ, Castro-Martínez P, Charpentier C, Argüelles-Arias F. González-Antuña J, et al. Among authors: arguelles arias f. Therap Adv Gastroenterol. 2024 Sep 9;17:17562848241271980. doi: 10.1177/17562848241271980. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39257470 Free PMC article.
Long-Term Outcomes of Intravenous Ustekinumab Maintenance Treatment in Patients With Loss of Response to Subcutaneous Dosing.
Argüelles-Arias F, Rodriguez González FJ, González Antuña J, Castro Laria L, Gutiérrez Martinez F, Alcaín Martinez G, Maldonado Pérez B, Camargo Camero R, Martos Van Dussen JV, Fernández Castañer A, Valdés Delgado T. Argüelles-Arias F, et al. Inflamm Bowel Dis. 2024 Jul 31:izae152. doi: 10.1093/ibd/izae152. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39082955
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA.
Gargallo-Puyuelo CJ, Ricart E, Iglesias E, de Francisco R, Gisbert JP, Taxonera C, Mañosa M, Aguas Peris M, Navarrete-Muñoz EM, Sanahuja A, Guardiola J, Mesonero F, Rivero Tirado M, Barrio J, Vera Mendoza I, de Castro Parga L, García-Planella E, Calvet X, Martín Arranz MD, García S, Sicilia B, Carpio D, Domenech E, Gomollón F; ENEIDA registry of GETECCU. Gargallo-Puyuelo CJ, et al. Clin Gastroenterol Hepatol. 2024 Nov;22(11):2280-2290. doi: 10.1016/j.cgh.2024.05.013. Epub 2024 May 22. Clin Gastroenterol Hepatol. 2024. PMID: 38782172
121 results